Pachyonychia Congenita
📧 Sign up to get email alerts when something new happens for Pachyonychia Congenita.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Epidermal Growth Factor Receptor Inhibition for Keratinopathies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating epidermal growth factor receptor inhibition for keratinopathy diseases, including Epidermolytic ichthyos…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases [Phase 1]
A Phase 1 trial update notes completion of a study evaluating the safety and potential efficacy of a 1% topical KM-001 formulation for Punct…
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Simvastatin Treatment of Pachyonychia Congenita [NA]
A clinical trial update indicates a study evaluating simvastatin for Pachyonychia Congenita, sponsored by Tel-Aviv Sourasky Medical Center, …
-
CLINICAL_TRIALS research · 2011-03-09Clinical Trial Update: Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita [Phase 2]
Phase 2 clinical trial update on Botulinumtoxin A for Epidermolysis Bullosa Simplex and Pachyonychia Congenita; sponsor is Uppsala Universit…